ADHD medicine recalled over drug mix-up, bottles might have unsuitable tablet
A pharmaceutical firm is recalling medicine for ADHD (consideration deficit hyperactivity dysfunction) and narcolepsy as a result of packages of the drug might include the unsuitable capsules, the U.S. Meals and Drug Administration is reporting.
The product is being recalled after a pharmacist in Nebraska opened a bottle of Zenzedi tablets and located tablets of Carbinoxamine Maleate, an antihistamine drug, the federal drug company introduced in a Jan. 24 recall.
Zenzedi is used to deal with narcolepsy, a sleep problem, and likewise typically used as a remedy for ADHD.
Upon studying of the incident, the FDA wrote, the producer, Woburn, Massachusetts-based Azurity Prescribed drugs, opened a product criticism and an investigation.
The corporate then immediatly despatched recall notification letters by way of in a single day supply to wholesale distributors, the FDA reported.
What else is being recalled?Test USA TODAY’s recall database
What ADHD medicine is being recalled?
Azurity Prescribed drugs is voluntarily recalling one lot of Zanzedi 30 mg with lot quantity F230169A.
The drug has an expiration date of June 2025, the FDA wrote in its recall, and was shipped to wholesalers from Aug. 23, 2023 by means of Nov. 29, 2023.
ADHD medicine recall: Potential side-effects of tablet mix-up
Individuals who take carbinoxamine as an alternative of Zenzedi will expertise “undertreatment of their signs” the FDA reported, which can result in impairment and an elevated threat of accidents and harm. Opposed results embody drowsiness, sleepiness and different severe circumstances together with thyroid dysfunction.
Sufferers with ADHD and narcolepsy will seemingly expertise accidents or accidents because of the sedating results of carbinoxamine which in some situations, can result in incapacity or demise, notably if folks utilizing it take part in actions requiring “important focus and application” together with driving or working equipment, the FDA stated.
Sleep apnea machine recall:Philips to halt gross sales of sleep apnea machines in US over ongoing security issues
What to do if you’re affected by the ADHD medicine recall
Customers who bought the affected drug ought to cease utilizing it instantly and speak to their healthcare supplier if they’ve skilled any issues probably associated to taking or utilizing it.
They’ll additionally report the medical difficulty to the FDA by filling out this way on-line or by calling 800-332-1088.
Customers with questions can even name (877) 804-2069.
Natalie Neysa Alund is a senior reporter for USA TODAY. Attain her at nalund@usatoday.com and comply with her on X @nataliealund.
